Table 2 |
|||
|
Design of the antidepressant experiment |
|||
|
Drug |
Treatment (days) |
Group ID |
N |
|
|
|||
|
Mirtazapine |
1 |
a1 |
3 |
|
Mirtazapine |
7 |
a7 |
3 |
|
Mirtazapine |
28 |
a28 |
5 |
|
Paroxetine |
1 |
p1 |
5 |
|
Paroxetine |
7 |
p7 |
5 |
|
Paroxetine |
28 |
p28 |
3 |
|
Vehicle |
28 |
c28 |
5 |
|
Total |
29 |
||
|
|
|||
|
Twenty-nine 12-week-old male mice of genotype 129SvJ were treated with the drug mirtazapine (a), paroxetine (p) or vehicle (c) by mouth for 1, 7 or 28 days at a dose of 40 mg per kg body weight. The untreated control group (c28) was used to normalize the data and does not appear in Figures 7 and 8. |
|||
|
Landgrebe et al. Genome Biology 2002 3:research0019.1 doi:10.1186/gb-2002-3-4-research0019 |
|||
